212
Participants
Start Date
June 1, 2019
Primary Completion Date
August 31, 2025
Study Completion Date
September 30, 2026
AGEN2034
PD-1 antibody
AGEN1884
CTLA-4 antibody
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok
Ramathibodi Hospital, Mahidol University, Bangkok
Mackay Memorial Hospital Taipei Branch, Taipei
Albert Einstein College of Medicine, The Bronx
Northwell Health Monter Cancer Center, Lake Success
Taipei Veterans General Hospital, Taipei
Koo Foundation Sun Yat-Sen Cancer Center, Taipei
SUNY Upstate Medical University, Syracuse
Clinica MonteSur, Centro de Investigación Clínica Montesur RCI -259, Lima Lima
WellSpan Gynecologic Oncology, York
Levine Cancer Institute, Charlotte
FirstHealth Outpatient Cancer Center, Pinehurst
Northside Hospital, Atlanta
Baptist MD Anderson Cancer Center, Jacksonville
Moffitt Cancer Center, Tampa
University of South Alabama Mitchell Cancer Institute, Mobile
University of Kentucky Albert B. Chandler Hospital, Lexington
Taichung Veterans General Hospital, Taichung
The Ohio State University Wexner Medical Center, Columbus
Columbus NCORP, Columbus
MetroHealth Medical Center, Cleveland
Community Health Network - North Cancer Center, Indianapolis
Christus Muguerza Hospital Vidriera, Monterrey
Oaxaca Site Management Organization (OSMO), Oaxaca City
Ochsner Clinic Foundation, New Orleans
Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
Texas Oncology - Dallas - Presbyterian Cancer Center, Dallas
The University of Texas Southwestern Medical Center, Dallas
Texas Oncology, Tyler
Texas Oncology - Bedford, Bedford
Cancerologia De Queretaro, Querétaro
Texas Oncology - Fort Worth Cancer Center, Fort Worth
Texas Oncology - The Woodlands, The Woodlands
Texas Oncology - San Antonio Medical Center, San Antonio
Texas Oncology Surgical Specialists - Austin Central, Austin
Arizona Oncology - Biltmore Cancer Center, Phoenix
Arizona Oncology - Tucson - Wilmot Road Location, Tucson
University of New Mexico Cancer Center, Albuquerque
UCLA- Women's Health Clinical Research Unit (WHCRU), Los Angeles
University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
Gynecologic Oncology Associates, Newport
University of California, San Francisco Medical Center, San Francisco
Northwest Cancer Specialists, P.C., Portland
Willamette Valley Cancer Institute, Eugene
University of Alabama at Birmingham School of Medicine, Birmingham
California Pacific Medical Center, San Francisco
St Joseph's Hospital, Savannah
MD Anderson Cancer Center at Cooper, Camden
Stephenson Cancer Center, Oklahoma City
Penn Medicine - Jordan Center for Gynecologic Cancer, Philadelphia
Women & Infants Hospital of Rhode Island, Providence
CRIO - Centro Regional Integrado de Oncologia, Fortaleza
Hospital Santa Rita, Vitória
IMIP - Instituto de Medicina Integral Prof. Fernando Figueira, Recife
ONCOSITE/Hospital de Caridade de Ijuí, Ijuí
Hospital Mãe de Deus, Porto Alegre
CECOR - Centro Oncológico de Roraima, Boa Vista
Hospital de Câncer de Barretos, Barretos
INCA - Instituto Nacional de Câncer, Rio de Janeiro
Instituto do Câncer do Estado de São Paulo, São Paulo
Perola Centro de Pesquisa em Oncologia, São Paulo
Hospital Amaral Carvalho, São Paulo
Fundação Antonio Prudente/AC Camargo Cancer Center, São Paulo
COI Centro Oncológico Internacional S.A.P.I. de C.V., Mexico City
Seoul National University, Seoul
Gangnam Severence Hospital, Seoul
Samsung Medical Center, Seoul
Lead Sponsor
GOG Foundation
NETWORK
Agenus Inc.
INDUSTRY